| Equus caballus |
Ferritin light chain |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adrenergic receptor beta |
Activity |
-11.5 |
None |
10.1016/S0960-894X(97)00046-2 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Caco-2 |
logPapp |
-4.44 |
None |
10.1016/j.bmc.2009.08.022 |
| Homo sapiens |
Caco-2 |
logPapp |
-4.44 |
None |
10.1016/j.bmc.2011.03.011 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 1A2 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2B6 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C19 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C8 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C9 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
326.4 |
nM |
None |
| Homo sapiens |
Glutaminase kidney isoform, mitochondrial |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-9.4 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
7.12 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
F |
100.0 |
% |
10.1124/dmd.111.041665 |
| Homo sapiens |
Interleukin-8 |
Potency |
66824.2 |
nM |
None |
| Homo sapiens |
Liver microsome |
CLH |
nan |
None |
10.1124/dmd.111.039180 |
| Homo sapiens |
Liver microsome |
Drug metabolism |
nan |
None |
10.1124/dmd.111.039180 |
| Homo sapiens |
Liver microsome |
PB |
30.9 |
pmol |
10.1124/dmd.111.039180 |
| Homo sapiens |
Liver microsomes |
Activity |
31.0 |
pmol |
10.1021/tx300075j |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nicotinate phosphoribosyltransferase |
Ki |
1.0 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
47307.9 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
63.1 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Skin |
log Kp |
-6.62 |
None |
10.1016/j.bmc.2007.07.050 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
63095.7 |
nM |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
Mus musculus |
ED40 |
60.0 |
mg kg-1 |
10.1021/jm00191a017 |
| Mus musculus |
Mus musculus |
ED50 |
19.2 |
mg.kg-1 |
10.1021/jm00370a020 |
| Mus musculus |
Mus musculus |
ED50 |
40.0 |
mg.kg-1 |
10.1021/jm00191a017 |
| Mus musculus |
Mus musculus |
ED50 |
46.0 |
mg.kg-1 |
10.1021/jm00187a013 |
| Mus musculus |
Mus musculus |
ED50 |
53.3 |
mg.kg-1 |
10.1021/jm00187a014 |
| Mus musculus |
Mus musculus |
ED50 |
233.0 |
mg.kg-1 |
10.1021/jm00187a014 |
| Mus musculus |
Mus musculus |
ED50 |
250.0 |
mg.kg-1 |
10.1021/jm00191a017 |
| Mus musculus |
Mus musculus |
ED50 |
640.0 |
mg.kg-1 |
10.1021/jm00187a014 |
| Mus musculus |
Mus musculus |
ED50 |
nan |
None |
10.1021/jm00187a014 |
| Mus musculus |
Mus musculus |
LD50 |
385.0 |
mg.kg-1 |
10.1021/jm00187a014 |
| Mus musculus |
Mus musculus |
LD50 |
420.0 |
mg.kg-1 |
10.1021/jm00187a013 |
| Mus musculus |
Mus musculus |
LD50 |
523.0 |
mg.kg-1 |
10.1021/jm00187a014 |
| Mus musculus |
Mus musculus |
LD50 |
523.0 |
mg.kg-1 |
10.1021/jm00370a020 |
| Mus musculus |
Mus musculus |
LD50 |
800.0 |
mg.kg-1 |
10.1021/jm00191a017 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
3696.4 |
nM |
None |
| Rattus norvegicus |
Colon |
log%Abs |
1.32 |
None |
10.1021/jm00211a010 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
nan |
None |
10.1021/jm00187a014 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
11.0 |
% |
10.1021/jm00187a013 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
17.5 |
% |
10.1021/jm00370a020 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
21.0 |
% |
10.1016/s0960-894x(01)00008-7 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
25.0 |
% |
10.1021/jm00187a013 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
48.2 |
% |
10.1021/jm00187a013 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
66.0 |
% |
10.1021/jm00211a016 |
| Rattus norvegicus |
Rattus norvegicus |
LD50 |
511.0 |
mg.kg-1 |
10.1021/jm00187a014 |
| Rattus norvegicus |
Rattus norvegicus |
LD50 |
2000.0 |
mg.kg-1 |
10.1021/jm00187a014 |
| Rattus norvegicus |
Rattus norvegicus |
LD50 |
2560.0 |
mg.kg-1 |
10.1021/jm00187a014 |
| Rattus norvegicus |
Small intestine |
log%Abs |
1.52 |
None |
10.1021/jm00211a010 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Inhibition |
23.8 |
% |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
100000.0 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
16.17 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
27.62 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1344 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.04 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.03 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
23.9 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.1753 |
None |
10.1101/2020.04.03.023846 |
| None |
ADMET |
CL |
3.47 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
nan |
None |
10.1124/dmd.111.039180 |
| None |
ADMET |
log10(%HIA +10) |
2.041 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
ADMET |
logPapp |
-4.44 |
None |
10.1124/dmd.111.041665 |
| None |
ADMET |
LogP app |
-462.0 |
None |
10.1016/j.bmc.2007.03.040 |
| None |
ADMET |
LogP app |
-4.76 |
None |
10.1016/j.bmc.2007.03.040 |
| None |
ADMET |
LogP app |
-4.41 |
None |
10.1016/j.bmc.2007.03.040 |
| None |
ADMET |
LogP app |
-4.3 |
None |
10.1016/j.bmc.2007.03.040 |
| None |
ADMET |
LogP app |
-4.14 |
None |
10.1016/j.bmc.2007.03.040 |
| None |
ADMET |
logPm |
-4.23 |
None |
10.1016/j.bmc.2007.03.040 |
| None |
ADMET |
Papp |
72.31 |
10^-6 cm/s |
10.1016/j.bmc.2007.03.040 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1016/j.ejmech.2010.01.071 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
No relevant target |
LogD |
0.58 |
None |
10.1021/jm00211a010 |
| None |
No relevant target |
LogD |
0.63 |
None |
10.1124/dmd.111.041665 |
| None |
No relevant target |
LogD |
1.0 |
None |
10.1021/jf102525e |
| None |
No relevant target |
LogD7.4 |
0.78 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
LogP |
-1.1 |
None |
10.1021/jm010289a |
| None |
No relevant target |
LogP |
-0.59 |
None |
10.1021/jm00218a017 |
| None |
No relevant target |
LogP |
-0.2 |
None |
10.1021/jm00218a017 |
| None |
No relevant target |
LogP |
0.76 |
None |
10.1021/jm00211a010 |
| None |
No relevant target |
LogP |
0.82 |
None |
10.1021/jm010289a |
| None |
No relevant target |
LogP |
1.0 |
None |
10.1016/j.bmc.2007.03.040 |
| None |
No relevant target |
LogP |
1.0 |
None |
10.1021/jf102525e |
| None |
No relevant target |
LogP |
19.0 |
None |
10.1021/jm00379a002 |
| None |
No relevant target |
logPapp |
-4.76 |
None |
10.1021/jf102525e |
| None |
No relevant target |
Log PNalk |
-0.68 |
None |
10.1021/jm048980b |
| None |
No relevant target |
pKa |
0.0 |
None |
10.1021/jf102525e |
| None |
No relevant target |
pKa |
0.3 |
None |
10.1021/jm00211a010 |
| None |
No relevant target |
pKa |
1.8 |
None |
10.1021/jm00211a010 |
| None |
No relevant target |
pKa |
4.48 |
None |
10.1016/j.bmc.2007.03.040 |
| None |
Unchecked |
Ac50 |
0.631 |
uM |
None |
| None |
Unchecked |
AC50 |
631.0 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
6.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |